A Mother’s Resilience: How One Woman’s Fight Against HIV Became a Beacon of hope
Table of Contents
On World AIDS Day, the story of Maya Kate serves as a powerful reminder that with access to treatment and unwavering support, a life with HIV can be a life lived fully. In 2005, Maya, then 24, faced unimaginable loss – her husband succumbed to Acquired Immunodeficiency Syndrome (AIDS), and days later, her newborn son also passed away. She lived under the shadow of her own diagnosis, fearing for her three-and-a-half-year-old daughter’s future. Today,at 44,Maya is a peer counselor at Bel-Air Hospital in Panchgani,Maharashtra,drawing strength from her journey and helping others navigate the challenges of living with HIV.
From Devastation to Diagnosis
Maya’s story began in 2000, when she married shortly after completing Class XII and welcomed a daughter within a year. From 2003, her husband experienced recurring bouts of fever, fatigue, and herpes. The couple discovered his HIV status when Maya became pregnant and underwent routine testing. “My test was positive and doctors then asked my husband to get tested. That’s when our journey with the virus began,” she recalls.
Back then, knowledge about HIV was limited, and the stigma surrounding the disease was immense. Her husband insisted on keeping their diagnoses a secret. “There was so much fear and stigma. AIDS meant death,” Maya explains. The weight of this secrecy became unbearable,and she eventually confided in her mother. At the time, Maya was living with her husband’s family in a village near Wai in Satara district, witnessing his declining health and grappling with her own diagnosis.
Loss and a Turning Point
The year 2005 brought devastating loss. Her husband died of AIDS, and a month later, her newborn son also succumbed to the illness. “I kept having nightmares that I would be the next.I lived only for my daughter,” Maya says, describing the profound grief and uncertainty that consumed her. Seeking support, she turned to Bel-Air Hospital in Panchgani, a leading HIV care center during a notably challenging period in India.
Her initial CD4 count was 450 cells/mm (normal being 500-1,500). Despite experiencing depression and weakness, she didn’t initially exhibit severe physical symptoms. She began volunteering at Bel-Air at the encouragement of Father Tomy Kariyilakulam, sharing her story with critically ill patients to offer them hope. Though, as her CD4 count dropped to 250, her resolve wavered.
The Lifesaving Impact of ART
In 2007, Maya began antiretroviral therapy (ART). “My weight had dropped to 38 kg and I couldn’t keep food down,” she remembers. She initially started on Triomune, a combination tablet taken twice daily, but experienced vomiting. After a switch to ZLN (Zidovudine, Lamivudine and Nevirapine) caused severe anemia, she transitioned to TLE (Tenofovir, lamivudine, Efavirenz) in 2010, remaining on this regimen for twelve years.
accessing medication wasn’t always easy. “In the early days, there was a huge rush because there were very few centres,” Maya says. She faced long waits and extensive testing at Satara Civil Hospital, requiring a one-and-a-half-hour journey each way to collect her monthly supply. The establishment of sub-centers later reduced her travel time, but the logistical burden remained notable.
two years ago, she was switched to the TLD regimen, but worsening joint pain necessitated another change. Currently on second-line treatment, Maya onc again travels one-and-a-half hours to Satara Civil Hospital. “It’s tiring, but worth it because I am adjusting well,” she affirms.
With consistent treatment, Maya’s viral load has become undetectable, allowing her to navigate the COVID-19 pandemic with the same resilience she’s demonstrated for two decades. “There are days I don’t complain at all,” she says. “But sometimes I wonder, ‘Why me?’ Still, I am alive, and my daughter-who fortunately did not test positive-is now married and settled.That keeps me going.”
Addressing the Broader Picture
According to the India HIV Estimations 2024 report, an estimated 2.6 million people in India are living with HIV, including 70,000 children. the country recorded 64,000 new infections in 2023 and 32,000 in 2024 – equating to four deaths every hour. “The biggest global challenge – access to ART – was overcome largely due to india’s pivotal role in making treatment affordable and accessible to almost 92% of people living with HIV globally,” states Dr. I.S. Gilada, President Emeritus of the AIDS Society of India. “Now the major challenges are stigma and discrimination; these require innovation,” he adds. He also cautioned against complacency, highlighting emerging hotspots and spikes in infections in the northeastern states and Punjab, frequently enough linked to injectable drug use.
ART’s ability to reduce viral load to undetectable levels transforms HIV into a manageable chronic condition. Eliminating mother-to-child transmission (MTCT) remains a critical goal. While 80% of pregnant women are screened for HIV, only 64% of those who test positive receive thorough MTCT prevention, leaving a gap that can lead to undiagnosed cases and incomplete adherence to lifelong ART and antenatal care. A visual portrayal of MTCT prevention rates by region would highlight areas needing increased intervention.
“Each new HIV case is a ‘missed opportunity.’ Every AIDS-related death is a grim reminder that it could have been prevented-we have the tools to make AIDS deaths history,” emphasizes Dr. Gilada.For Maya, those tools have provided 20 more years of life, the joy of seeing her daughter thrive, and a renewed purpose in helping others overcome the fear she once knew so intimately.
